Adma Biologics Inc. Revenue 2011–2025
Adma Biologics Inc. annual/quarterly revenue history and growth rate from 2011 to 2026. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sale of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
- Adma Biologics Inc. revenue for the quarter ending March 31, 2026 was 114.5 M, a 0.27% decrease year-over-year.
- Adma Biologics Inc. revenue for the twelve months ending March 31, 2026 was 485.5 M, a 29.06% increase year-over-year.
- Adma Biologics Inc. annual revenue for 2025 was 510.2 M, a 19.63% increase from 2024.
- Adma Biologics Inc. annual revenue for 2024 was 426.5 M, a 65.15% increase from 2023.
- Adma Biologics Inc. annual revenue for 2023 was 258.2 M, a 67.59% increase from 2022.
- Adma Biologics Inc. annual revenue for 2022 was 154.1 M.
Adma Biologics Inc. (ADMA) — Frequently Asked Questions
Adma Biologics Inc. (ADMA) is a publicly traded US company. It has a market capitalization of $2.08B. In fiscal 2025 it reported revenue of $510M and net income of $147M. Explore ADMA's stock price, financial statements, earnings history, margins and key ratios below.
What is Adma Biologics Inc.'s market cap?
Adma Biologics Inc. (ADMA) has a market capitalization of $2.08B.
What is the ADMA stock price?
ADMA trades at $8.48 (+4.43% on the day).
How much revenue does Adma Biologics Inc. make?
Adma Biologics Inc. reported revenue of $510M in fiscal 2025.
Is ADMA profitable?
In fiscal 2025, Adma Biologics Inc. reported net income of $147M.